Delivery Order SPE2DB20D3103-SPE2DB24FM4U8
Award Date 1/30/24
Potential Completion Date 1/31/24
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Capecitabine 500 mg tablets. The contract has a ceiling value of $6,330.32 and an ultimate completion date of October 19, 2023. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider...
- The Defense Logistics Agency awarded a $7,701.04 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 120 tablets of Capecitabine 500 mg, with an ultimate completion date of November 7, 2025. This is a non-set-aside competitive award issued to AmerisourceBergen's Corporate Office division, with performance at the company's Conshohocken, Pennsylvania headquarters. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of 4563298237 - CAPECITABINE 500 MG TABLET 120S, a pharmaceutical product. The $3,091.60 firm fixed-price contract has an ultimate completion date of January 11, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as...
- This federal contract award, valued at $1,699.58, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order that provides various pharmaceutical products, including capsules, to support military healthcare programs. The award has an ultimate completion date of November 7, 2023 and is a firm fixed price contract. This appears to be part of a larger Indefinite Delivery Contract (IDC) that...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., provides pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The $10,928.48 Firm Fixed Price Delivery Order covers the procurement of CAPLYTA 10.5 MG CAPSULE 30S, with a performance period through December 27, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., provides $21,169.14 in Firm Fixed Price delivery orders for XELODA 500 MG TABLET 120S, a pharmaceutical product. The award was made by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the DLA Troop Support Medical, which...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order (SPE2DB20D2104|SPE2DB24FT00S) valued at $1,182.71 for pharmaceutical products. The contract was awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of April 2, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as the primary vehicle for...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (DO) with a ceiling value of $10,646.41. The contract was awarded by the Defense Logistics Agency (DLA) and covers the delivery of CAPLYTA 42 MG CAPSULE 30S, a pharmaceutical product, with a period of performance through February 5, 2024. The contract is a Firm Fixed Price (FFP) arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for pharmaceutical and medical supply delivery to the Defense Logistics Agency (DLA) under a Delivery Order (DO) valued at $1,074.60. The contract has an ultimate completion date of April 5, 2021 and is a Firm Fixed Price Delivery Order with no set-aside designation, indicating full and open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $1,309.45 for the pharmaceutical product Xeljanz XR 11 mg tablets. The award was made by the Defense Logistics Agency (DLA), a defense agency, and is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the...